Background
Optimal adoption of the malaria transmission-blocking strategy is currently limited by lack of safe and efficacious drugs. This has sparked the exploration of different sources of drugs in search of transmission-blocking agents. While plant species have been extensively investigated in search of malaria chemotherapeutic agents, comparatively less effort has been channelled towards exploring them in search of transmission-blocking drugs.
Artemisia afra
(Asteraceae), a prominent feature of South African folk medicine, is used for the treatment of a number of diseases, including malaria. In search of transmission-blocking compounds aimed against
Plasmodium
parasites, the current study endeavoured to isolate and identify gametocytocidal compounds from
A. afra
.
Methods
A bioassay-guided isolation approach was adopted wherein a combination of solvent–solvent partitioning and gravity column chromatography was used. Collected fractions were continuously screened in vitro for their ability to inhibit the viability of primarily late-stage gametocytes of
Plasmodium falciparum
(NF54 strain), using a parasite lactate dehydrogenase assay. Chemical structures of isolated compounds were elucidated using UPLC-MS/MS and NMR data analysis.
Results
Two guaianolide sesquiterpene lactones, 1α,4α-dihydroxybishopsolicepolide and yomogiartemin, were isolated and shown to be active (IC
50
< 10 μg/ml; ~ 10 μM) against both gametocytes and intra-erythrocytic asexual
P. falciparum
parasites. Interestingly, 1α,4α-dihydroxybishopsolicepolide was significantly more potent against late-stage gametocytes than to early-stage gametocytes and intra-erythrocytic asexual
P. falciparum
parasites. Additionally, both isolated compounds were not overly cytotoxic against HepG2 cells in vitro.
Conclusion
This study provides the first instance of isolated compounds from
A. afra
against
P. falciparum
gametocytes as a starting point for further investigations on more plant species in search of transmission-blocking compounds.
Electronic supplementary material
The online version of this article (10.1186/s12936-019-2694-1) contains supplementary material, which is available to authorized users.
The unexpected conversion of benzoylbenzofurans into isoflavones through an intramolecular cascade that involves deprotection and ring-opening/cyclization is described. This was discovered in an investigation of the possible transformation of benzoylbenzofurans into coumaronochromones. This route affords isoflavones in two major steps from acetophenones and benzoquinones. The transformation was validated by synthesizing differently substituted isoflavone derivatives and further applied to a concise synthesis of a potential anticancer lead compound, glaziovianin A (1).
A robust process technology for the manufacture of the active pharmaceutical ingredient (API) amodiaquine dihydrochloride dihydrate (ADQ, 3), an important antimalarial, is reported. The process consists of a three-step synthetic route that involves a Mannich reaction, condensation with 4,7-dichloroquinoline (DCQ, 5) and rehydration. Additionally, a cost-competitive process for the production of DCQ (5) is also reported wherein DCQ (5) was prepared in four steps from meta-chloroaniline (7). 4-Amido-2-(diethylaminomethyl)phenol (14), DCQ (5), and ADQ (3) were obtained in yields of 92, 89 and 90% respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.